Related Experiment Video
Updated: Jul 26, 2026
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
[Alpha interferons--new therapeutic modalities]
M Bajcetić1, N Zigon, R Samardzić
1Institut za klinicku farmakologiju, farmakologiju i toksikologiju, Medicinski fakultet, Beograd.
Medicinski Pregled
|June 5, 1998
Summary
Alpha-interferons are signaling proteins with antiviral, anticancer, and immunomodulatory effects. They show significant therapeutic value in treating various cancers and viral infections, though high cost can limit accessibility.
Area of Science:
- Immunology
- Oncology
- Virology
Context:
- Interferons (IFNs) are crucial intercellular signaling proteins with diverse biological roles.
- Three main classes exist: alpha, beta, and gamma, with alpha-interferons (IFN-α) being the focus of this review.
- Both natural and recombinant forms of IFN-α are available, with recombinant IFN-α 2a and 2b being widely used.
Purpose:
- To review the current therapeutic applications and implications of alpha-interferons.
- To highlight the efficacy of IFN-α in various hematological malignancies and viral diseases.
- To discuss the potential of IFN-α in combination therapies and other emerging applications.
Summary:
- Alpha-interferons exhibit potent antiviral, anticancer, and immunomodulatory activities.
- Clinical trials confirm IFN-α's value as a first-line or adjuvant therapy for hairy cell leukemia, hepatitis B and C, and condylomata acuminata.
- IFN-α is also effective in managing chronic myelogenous leukemia, lymphomas, Kaposi's sarcoma, and other viral infections, with response rates varying by condition.
Impact:
- IFN-α therapy represents an important treatment modality for hematological diseases, malignancies, and viral infections.
- Despite high efficacy, the significant cost of IFN-α treatment can restrict its use, often positioning it as a second-line therapy.
- Further research into combination therapies and cost-effectiveness is essential to broaden the application of alpha-interferons.
More Related Videos
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
Related Concept Videos
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:26Cholinergic Antagonists: Therapeutic Uses
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...